Novo Nordisk A/S (NVO)

63.85 +0.34  +0.54% NYSE Feb 21, 20:00 Delayed 2m USD

Novo Nordisk Cash from Operations (TTM):

7.015B for Dec. 31, 2019
View 4,000+ financial data types
Browse...
View Full Chart

Cash from Operations (TTM) Chart

Export Data
Save Image
Print Image

Historical Cash from Operations (TTM) Data

View and export this data going back to 1984. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Dec. 31, 2019 7.015B
Sept. 30, 2019 7.465B
June 30, 2019 6.718B
March 31, 2019 6.953B
Dec. 31, 2018 7.067B
Sept. 30, 2018 6.515B
June 30, 2018 7.081B
March 31, 2018 6.152B
Dec. 31, 2017 6.266B
Sept. 30, 2017 7.162B
June 30, 2017 7.130B
March 31, 2017 7.809B
Dec. 31, 2016 7.181B
Sept. 30, 2016 7.073B
June 30, 2016 6.651B
March 31, 2016 6.179B
Dec. 31, 2015 5.696B
Sept. 30, 2015 5.510B
June 30, 2015 5.793B
March 31, 2015 5.528B
Dec. 31, 2014 5.653B
Sept. 30, 2014 5.301B
June 30, 2014 4.346B
March 31, 2014 4.115B
Dec. 31, 2013 4.619B
   
Sept. 30, 2013 4.017B
June 30, 2013 4.151B
March 31, 2013 4.102B
Dec. 31, 2012 3.836B
Sept. 30, 2012 4.169B
June 30, 2012 4.332B
March 31, 2012 4.041B
Dec. 31, 2011 3.993B
Sept. 30, 2011 4.241B
June 30, 2011 3.919B
March 31, 2011 3.654B
Dec. 31, 2010 3.503B
Sept. 30, 2010 3.173B
June 30, 2010 3.086B
March 31, 2010 2.938B
Dec. 31, 2009 2.878B
Sept. 30, 2009 2.863B
June 30, 2009 2.522B
March 31, 2009 2.650B
Dec. 31, 2008 2.541B
Sept. 30, 2008 2.400B
June 30, 2008 2.371B
March 31, 2008 2.007B
Dec. 31, 2007 1.839B
Sept. 30, 2007 1.425B

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Cash From Operations

An item on a company's cash flow statement. Lists aggregate change in cash position resulting from operations. Includes the company's cash inflows and outflows from the company's core business operations.

Cash from Operations can be thought of as "how much did the firm generate in the day to day operations of the firm?"
Learn More

Advertisement

Cash from Operations (TTM) Benchmarks

Benchmarks
Eli Lilly and Co 4.837B
Sanofi SA --
Zealand Pharma A/S -60.30M

Cash from Operations (TTM) Range, Past 5 Years

Minimum 5.510B Sep 2015
Maximum 7.809B Mar 2017
Average 6.647B
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.